Feedback / Questions
AU-007 - Aulos Biosci
https://www.businesswire.com/news/home/20230927350421/en/Aulos-Bioscience-Announces-Presentation-of-Updated-Safety-and-Efficacy-Data-From-First-in-Human-Phase-12-Clinical-Trial-of-AU-007-at-38th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting
Sep 27, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next